These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Ataxia-opsoclonus-myoclonus syndrome]. Pinsard N; Pons-Cerdan C; Mancini J; Livet MO; Bernard R Sem Hop; 1981 Mar 8-15; 57(9-10):488-94. PubMed ID: 6261394 [TBL] [Abstract][Full Text] [Related]
26. Corticotrophin and its synthetic analogues. Br Med J; 1969 Jun; 2(5660):809-11. PubMed ID: 4306559 [No Abstract] [Full Text] [Related]
27. Forty-one year follow-up of childhood-onset opsoclonus-myoclonus-ataxia: cerebellar atrophy, multiphasic relapses, and response to IVIG. Pranzatelli MR; Tate ED; Kinsbourne M; Caviness VS; Mishra B Mov Disord; 2002 Nov; 17(6):1387-90. PubMed ID: 12465092 [TBL] [Abstract][Full Text] [Related]
28. [Glucocorticoids--pro and contra. Possibilities for use of dexamethasone in neurology and neurosurgery (II)]. Schulte RM Med Welt; 1983 Jul; 34(28):793-8. PubMed ID: 6350805 [No Abstract] [Full Text] [Related]
29. Corticosteroids in ischemic stroke. Anderson DC; Cranford RE Stroke; 1979; 10(1):68-71. PubMed ID: 432902 [No Abstract] [Full Text] [Related]
30. Surgical treatment of pseudotumor cerebri. Smith CH; Orcutt JC Int Ophthalmol Clin; 1986; 26(4):265-75. PubMed ID: 3804630 [No Abstract] [Full Text] [Related]
31. Corticotropin and corticosteroids in generalized myasthenia gravis: comparative studies and role in management. Brunner NG; Berger CL; Namba T; Grob D Ann N Y Acad Sci; 1976; 274():577-95. PubMed ID: 183590 [TBL] [Abstract][Full Text] [Related]
32. Corticosteroid treatment of optic neuritis: a need to change treatment practices. The Optic Neuritis Study Group. Beck RW Neurology; 1992 Jun; 42(6):1133-5. PubMed ID: 1318520 [No Abstract] [Full Text] [Related]
33. [Clinico-etiological and therapeutic aspects of peripheral facial paralysis]. Taindel C; Dan B; Predescu I; Marcovici A; Ciugarin M Neurol Psihiatr Neurochir; 1967; 12(3):235-44. PubMed ID: 4299031 [No Abstract] [Full Text] [Related]
34. Treatment of ocular myasthenia with corticotrophin. Gibberd FB; Navab F; Smith CL J Neurol Neurosurg Psychiatry; 1971 Feb; 34(1):11-3. PubMed ID: 4323972 [TBL] [Abstract][Full Text] [Related]
35. Use of drugs in myopathies. Grob D Annu Rev Pharmacol Toxicol; 1976; 16():215-29. PubMed ID: 180877 [No Abstract] [Full Text] [Related]
36. The use of ACTH and corticosteroids in myasthenia gravis. Genkins G; Kornfeld P; Osserman KE; Namba T; Grob D; Brunner NG Ann N Y Acad Sci; 1971 Sep; 183():369-74. PubMed ID: 4330763 [No Abstract] [Full Text] [Related]
37. ACTH induced adrenal enlargement in infants treated for infantile spasms and acute cerebellar encephalopathy. Liebling MS; Starc TJ; McAlister WH; Ruzal-Shapiro CB; Abramson SJ; Berdon WE Pediatr Radiol; 1993; 23(6):454-6. PubMed ID: 8255650 [TBL] [Abstract][Full Text] [Related]
38. Use of corticosteroids in neuroophthalmology. Jampel RS Int Ophthalmol Clin; 1966; 6(4):903-13. PubMed ID: 4294918 [No Abstract] [Full Text] [Related]
39. [Optic neuritis in children and adolescents]. Madroszkiewicz M; Niebrój TK Cesk Oftalmol; 1974 May; 30(3):194-8. PubMed ID: 4849304 [No Abstract] [Full Text] [Related]